Capital raised by ImmunoVec
1 Form D filing · first filed Jun 2026 · Los Angeles, CA
Chief Executive Officer
Signatory on ImmunoVec's Form D filings · $12.7M raised across 1
Ryan Wong is on file as Chief Executive Officer at ImmunoVec in Los Angeles, CA. ImmunoVec has 1 Form D filing on record, $12.7M raised in total. Ryan Wong appears as a signatory on the company's filings.
LinkedIn profileA platform of programmable DNA medicines that reprogram immune and other cell types directly within the body, led by a pre-clinical in vivo cell therapy program for autoimmune diseases funded by the ARPA-H EMBODY program.